Seropositivity rate, anti-spike antibody titre higher in Covishield than Covaxin: Study
India | June 06, 2021 21:18 ISTThe study is titled, Antibody Response after Second-dose of ChAdOx1-nCOV (CovishieldTM) and BBV-152 (CovaxinTM) among Health Care Workers in India: Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study published in MedRxiv.